MedPath
NMPA Approval

Nimodipine Injection

国药准字H20249601

December 1, 2024

Drug Information

尼莫地平注射液

注射剂

50ml∶10mg

化学药品

December 1, 2024

Company Information

Applicant Company

成都高新区和祥三街263号

Manufacturing Company

成都市双流西南航空港经济开发区空港四路1166号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

尼莫地平注射液 - NMPA 批准文号 | MedPath